STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Revenue growth
+11.4%
XBRL, annual
Net margin
-1.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$22.1M
four quarters, 2025-07-01 to 2026-06-30
History
FY Dec 2025
$20.7M
FY Dec 2024
$18.6M
FY Dec 2023
$16.6M
FY Dec 2022
$16.6M
FY Dec 2021
$14.9M
Jun 2026
$5.9M
Mar 2026
$5.3M
Dec 2025
$5.4M
Sep 2025
$5.5M
Jun 2025
$5.4M
Mar 2025
$4.4M
Dec 2024
$5.4M
Sep 2024
$4.4M
At each fiscal year end
Single quarter
Net margin, TTM
+0.6%
net income over revenue, 2025-07-01 to 2026-06-30
History
FY Dec 2025
-1.8%
FY Dec 2024
+4.1%
FY Dec 2023
+2.1%
FY Dec 2022
+3.9%
FY Dec 2021
-4.7%
Jun 2026
-0.1%
Mar 2026
-0.8%
Dec 2025
+2.7%
Sep 2025
+0.6%
Jun 2025
-7.3%
Mar 2025
-3.4%
Dec 2024
-3.2%
Sep 2024
-3.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$282.7K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
History
FY Dec 2025
-$55.6K
FY Dec 2024
$441.1K
FY Dec 2023
n/a
FY Dec 2022
$801.4K
FY Dec 2021
n/a
Jun 2026
$216.8K
Mar 2026
-$132.8K
Dec 2025
$25.8K
Sep 2025
$172.8K
Jun 2025
$223.2K
Mar 2025
-$477.6K
Dec 2024
$590.4K
Sep 2024
-$219.4K
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
History
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
History
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+2.4%
TTM net income over average of 2025-06-30 and 2026-06-30
History
FY Dec 2025
-7.0%
FY Dec 2024
+16.7%
FY Dec 2023
+9.8%
FY Dec 2022
+21.9%
FY Dec 2021
-23.7%
Jun 2026
+2.4%
Mar 2026
-5.0%
Dec 2025
-7.0%
Sep 2025
-13.5%
Jun 2025
-16.7%
Mar 2025
+6.8%
Dec 2024
+16.7%
Sep 2024
+36.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.6%
TTM net income over average of 2025-06-30 and 2026-06-30
History
FY Dec 2025
-4.4%
FY Dec 2024
+9.9%
FY Dec 2023
+5.3%
FY Dec 2022
+10.1%
FY Dec 2021
-11.3%
Jun 2026
+1.6%
Mar 2026
-3.2%
Dec 2025
-4.4%
Sep 2025
-8.2%
Jun 2025
-10.2%
Mar 2025
+4.1%
Dec 2024
+9.9%
Sep 2024
+21.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
History
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-3.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
History
FY Dec 2025
-10.8%
FY Dec 2024
-9.0%
FY Dec 2023
-12.5%
FY Dec 2022
+1.5%
FY Dec 2021
-12.6%
Jun 2026
-3.7%
Mar 2026
-10.2%
Dec 2025
-10.8%
Sep 2025
-12.5%
Jun 2025
-15.4%
Mar 2025
-10.8%
Dec 2024
-9.0%
Sep 2024
-5.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
History
FY Dec 2025
n/a
FY Dec 2024
33.33x
FY Dec 2023
36.25x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
100.33x
Dec 2024
33.33x
Sep 2024
16.00x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
History
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+1.3%
TTM free cash flow over market value at close 2026-10-09
History
FY Dec 2025
-0.2%
FY Dec 2024
+1.8%
FY Dec 2023
n/a
FY Dec 2022
+7.9%
FY Dec 2021
n/a
Jun 2026
+1.5%
Mar 2026
+1.4%
Dec 2025
-0.2%
Sep 2025
+2.1%
Jun 2025
+0.5%
Mar 2025
+0.8%
Dec 2024
+1.8%
Sep 2024
+0.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
History
FY Dec 2025
n/a
FY Dec 2024
0.27x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
0.27x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-09. Hover a figure to see how it was computed.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
PAYD ranks highest on risk and compliance (90th percentile) and growth (65th), and lowest on profitability (41st), among Services peers.
Profitability
41
Inputs
Return on equity+2.4% · 41 pct, sector of 209
Return on assets+1.6% · 52 pct, sector of 270
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-3.7% · 31 pct, sector of 204
Growth
65
Inputs
Revenue growth, YoY+11.4% · 65 pct, sector of 343
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
90
Inputs
Short interest, % of float+0.0% · 100 pct, sector of 385
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+5.8% · 81 pct, sector of 228
4 not measured: Financial health, Insider conviction, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
No password to create and no card required. We store your email address and nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in. Google Analytics and
Microsoft Clarity load only if you allow them here, to show us which datasets matter.
No ad trackers, ever. Details in the privacy
policy.